Format

Send to

Choose Destination
See comment in PubMed Commons below
Mediators Inflamm. 2012;2012:236345. doi: 10.1155/2012/236345. Epub 2012 May 15.

Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.

Author information

1
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.

Abstract

Viruses are frequent causes of respiratory infection, and viral respiratory infections are significant causes of hospitalization, morbidity, and sometimes mortality in a variety of patient populations. Lung inflammation induced by infection with common respiratory pathogens such as influenza and respiratory syncytial virus is accompanied by increased lung production of prostaglandins and leukotrienes, lipid mediators with a wide range of effects on host immune function. Deficiency or pharmacologic inhibition of prostaglandin and leukotriene production often results in a dampened inflammatory response to acute infection with a respiratory virus. These mediators may, therefore, serve as appealing therapeutic targets for disease caused by respiratory viral infection.

PMID:
22665949
PMCID:
PMC3362132
DOI:
10.1155/2012/236345
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center